Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Bocunebart

Neuroscience

Neuroscience Video Recap—February 18, 2026

This biweekly Neuroscience video recap covers a range of key developments,…

Women's_Health

Women’s Health Video Recap—February 18, 2026

This biweekly Women’s Health video recap covers a range of developments,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Neuroscience Video Recap—February 18, 2026
Neuroscience Today—February 18, 2026
Women’s Health Video Recap—February 18, 2026
Immunology Today—February 18, 2026
Lucid Diligence Brief: Danaher to acquire Masimo in $9.9bn all-cash deal

Tags

Akero Therapeutics Allergan Aesthetics Berry Street GLP-1 Nutrition Big Nova Foundation Biopharma market trends Bristol Myers Squibb Cellectar Biosciences CEPI Charcot Marie Tooth disease type 1A Clinical trial simulations corporate transactions COVID-19 booster CRD-003 CT071 Desiccated thyroid extract Dyne endoscopic remission Fast Track Fore Biotherapeutics GanLum giredestrant GLP-1/GIP dual agonists Healthy aging hypertrophic cardiomyopathy icovamenib KYV-101 metabolic disease MoCD Type A Moligo Technologies Nemtabrutinib Neurescue Plaque Analysis ROS1 positive NSCLC Salbutamol SEAHEARTS sNDA Spren body scan SST2 agonist Structural heart disease Takeda Biopharmaceuticals VELSIPITY Verismo VTE Wiskott Aldrich syndrome Zambart

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Neuroscience Video Recap—February 18, 2026
Neuroscience Today—February 18, 2026
Women’s Health Video Recap—February 18, 2026
Immunology Today—February 18, 2026
Lucid Diligence Brief: Danaher to acquire Masimo in $9.9bn all-cash deal

TAGS

Akero Therapeutics Allergan Aesthetics Berry Street GLP-1 Nutrition Big Nova Foundation Biopharma market trends Bristol Myers Squibb Cellectar Biosciences CEPI Charcot Marie Tooth disease type 1A Clinical trial simulations corporate transactions COVID-19 booster CRD-003 CT071 Desiccated thyroid extract Dyne endoscopic remission Fast Track Fore Biotherapeutics GanLum giredestrant GLP-1/GIP dual agonists Healthy aging hypertrophic cardiomyopathy icovamenib KYV-101 metabolic disease MoCD Type A Moligo Technologies Nemtabrutinib Neurescue Plaque Analysis ROS1 positive NSCLC Salbutamol SEAHEARTS sNDA Spren body scan SST2 agonist Structural heart disease Takeda Biopharmaceuticals VELSIPITY Verismo VTE Wiskott Aldrich syndrome Zambart

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy